SPRY Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 40.10%

Insider Buying (Last 12 Months): $8,917,945.66

Insider Selling (Last 12 Months): $24,087,552.46

ARS Pharmaceuticals Insider Trading History Chart

ARS Pharmaceuticals Share Price & Price History

^$15.72

▲ +0.4 (2.61%)

As of 11/6/2024 05:00 PM ET

Days: 30 | 90 | 365

Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners

From Colonial Metals | Ad

Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…

Get Your Free Gold Guide

ARS Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/16/2024	Kathleen D Scott	CFO	Sell	12,500	$16.00	$200,000.00	4,949
10/15/2024	Sarina Tanimoto	Insider	Sell	100,000	$14.88	$1,488,000.00	1,298,499
10/8/2024	Richard E Lowenthal	CEO	Sell	100,000	$13.83	$1,383,000.00	1,346,494
9/18/2024	Eric Karas	Insider	Sell	10,000	$14.00	$140,000.00	5,693
9/17/2024	Richard E Lowenthal	CEO	Sell	100,000	$12.93	$1,293,000.00	1,398,499
8/26/2024	Peter A Thompson	Director	Sell	83,695	$13.00	$1,088,035.00
8/23/2024	Peter A Thompson	Director	Sell	69,500	$13.03	$905,585.00	83,695
8/21/2024	Peter A Thompson	Director	Sell	407,700	$13.56	$5,528,412.00	544,677
8/20/2024	Brian Dorsey	COO	Sell	50,000	$15.00	$750,000.00	6,024
8/20/2024	Kathleen D Scott	CFO	Sell	12,500	$16.00	$200,000.00	13,199
8/20/2024	Richard E Lowenthal	CEO	Sell	100,000	$15.03	$1,503,000.00	1,497,447
8/19/2024	Eric Karas	Insider	Sell	10,000	$14.00	$140,000.00	5,693
7/16/2024	Richard E Lowenthal	CEO	Sell	100,000	$11.40	$1,140,000.00	1,547,447
7/9/2024	Sarina Tanimoto	Insider	Sell	100,000	$9.62	$962,000.00	1,496,494
6/12/2024	Sarina Tanimoto	Insider	Sell	95,862	$9.15	$877,137.30	1,546,494
6/11/2024	Richard E Lowenthal	CEO	Sell	4,138	$9.00	$37,242.00	1,594,328
5/16/2024	Sarina Tanimoto	Insider	Sell	89,096	$9.06	$807,209.76	1,597,447
5/15/2024	Richard E Lowenthal	CEO	Sell	5,147	$9.05	$46,580.35	1,642,193
5/14/2024	Sarina Tanimoto	Insider	Sell	5,757	$9.01	$51,870.57	1,644,574
5/7/2024	Sarina Tanimoto	Insider	Sell	100,000	$9.34	$934,000.00	1,596,494
4/16/2024	Sarina Tanimoto	Insider	Sell	100,000	$9.28	$928,000.00	1,647,447
4/9/2024	Richard E Lowenthal	CEO	Sell	100,000	$9.28	$928,000.00	1,646,494
3/27/2024	Ra Capital Management, L.P.	Director	Buy	505,954	$9.79	$4,953,289.66	9,958,073
3/25/2024	Ra Capital Management, L.P.	Director	Buy	437,600	$9.06	$3,964,656.00	8,994,374
3/25/2024	Richard E Lowenthal	CEO	Sell	95,267	$9.12	$868,835.04	1,697,447
3/22/2024	Sarina Tanimoto	Insider	Sell	2,343	$9.02	$21,133.86	1,745,082
3/21/2024	Richard E Lowenthal	CEO	Sell	472	$9.00	$4,248.00	1,746,099
3/19/2024	Richard E Lowenthal	CEO	Sell	1,918	$9.03	$17,319.54	1,746,471
3/15/2024	Richard E Lowenthal	CEO	Sell	96,756	$9.14	$884,349.84	1,696,494
3/14/2024	Sarina Tanimoto	Insider	Sell	444	$9.00	$3,996.00	1,744,789
3/13/2024	Richard E Lowenthal	CEO	Sell	2,800	$9.00	$25,200.00	1,744,994
2/29/2024	Richard E Lowenthal	CEO	Sell	3,782	$9.02	$34,113.64	1,746,494
2/28/2024	Sarina Tanimoto	Insider	Sell	98,778	$9.02	$890,977.56	1,747,294
2/26/2024	Sarina Tanimoto	Insider	Sell	700	$9.01	$6,307.00	1,772,750
9/28/2023	Alexander A Fitzpatrick	Insider	Buy	40,000	$3.62	$144,800.00	42,969
9/21/2023	Ra Capital Management, L.P.	Director	Buy	2,700,000	$3.03	$8,181,000.00	8,556,774
9/1/2023	Laura Shawver	Director	Sell	100,000	$7.71	$771,000.00	210,346
8/29/2023	Ra Capital Management, L.P.	Director	Buy	3,750,000	$6.20	$23,250,000.00	5,856,774
8/4/2023	Laura Shawver	Director	Sell	18,897	$7.06	$133,412.82	210,346
8/2/2023	Laura Shawver	Director	Sell	36,281	$7.09	$257,232.29	210,346
7/6/2023	Laura Shawver	Director	Sell	33,510	$6.34	$212,453.40	210,346
7/3/2023	Laura Shawver	Director	Sell	26,520	$6.72	$178,214.40	210,346
6/1/2023	Laura Shawver	Director	Sell	73,059	$6.80	$496,801.20	210,346
5/9/2023	Laura Shawver	Director	Sell	42,900	$5.31	$227,799.00	210,346
11/29/2022	Kathleen D Scott	CFO	Buy	8,250	$6.24	$51,480.00	8,250

“This Changes Everything” - Trump Hands Millions Massive IRS Gift

From Colonial Metals | Ad

Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…

>> YES! Send Me My FREE Gold Guide!

SEC Filings (Institutional Ownership Changes) for ARS Pharmaceuticals (NASDAQ:SPRY)

68.16% of ARS Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

ARS Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/6/2024	Royce & Associates LP	691,455	$10.03M	0.1%	+7.1%	0.713%
11/5/2024	GSA Capital Partners LLP	98,900	$1.43M	0.1%	+67.7%	0.102%
10/28/2024	US Bancorp DE	18,680	$0.27M	0.0%	+11,951.6%	0.019%
10/25/2024	China Universal Asset Management Co. Ltd.	18,645	$0.27M	0.0%	+63.8%	0.019%
10/24/2024	J.W. Cole Advisors Inc.	20,520	$0.30M	0.0%	+33.2%	0.021%
10/24/2024	Wealth Enhancement Advisory Services LLC	57,624	$0.84M	0.0%	+9.1%	0.059%
10/22/2024	TFG Advisers LLC	12,399	$0.18M	0.1%	N/A	0.013%
10/19/2024	Allspring Global Investments Holdings LLC	178,221	$2.58M	0.0%	N/A	0.184%
10/18/2024	Raymond James & Associates	204,783	$2.97M	0.0%	N/A	0.211%
10/16/2024	nVerses Capital LLC	2,100	$30K	0.0%	N/A	0.002%
10/11/2024	Creative Planning	35,263	$0.51M	0.0%	+7.0%	0.036%
10/3/2024	SG Americas Securities LLC	58,304	$0.85M	0.0%	-47.8%	0.060%
8/15/2024	The Manufacturers Life Insurance Company	21,196	$0.18M	0.0%	N/A	0.022%
8/14/2024	Profund Advisors LLC	16,129	$0.14M	0.0%	-7.5%	0.017%
8/9/2024	Renaissance Technologies LLC	124,100	$1.06M	0.0%	+884.9%	0.128%
8/9/2024	Dimensional Fund Advisors LP	192,448	$1.64M	0.0%	-30.1%	0.199%
8/8/2024	J.W. Cole Advisors Inc.	15,400	$0.13M	0.0%	+10.8%	0.016%
8/8/2024	American Century Companies Inc.	97,803	$0.83M	0.0%	+20.7%	0.101%
8/7/2024	ClariVest Asset Management LLC	287,596	$2.45M	0.2%	+5.4%	0.297%
8/6/2024	Letko Brosseau & Associates Inc.	24,700	$0.21M	0.0%	-31.4%	0.025%
8/6/2024	Los Angeles Capital Management LLC	27,120	$0.23M	0.0%	N/A	0.028%
8/1/2024	Rhumbline Advisers	65,942	$0.56M	0.0%	+78.0%	0.068%
7/29/2024	Principal Financial Group Inc.	10,230	$87K	0.0%	N/A	0.011%
7/29/2024	FAS Wealth Partners Inc.	67,656	$0.58M	0.0%	+11.9%	0.070%
7/29/2024	Zurcher Kantonalbank Zurich Cantonalbank	7,419	$63K	0.0%	+151.7%	0.008%
7/26/2024	Bank of New York Mellon Corp	139,285	$1.19M	0.0%	+99.3%	0.144%
7/16/2024	Wealth Enhancement Advisory Services LLC	52,814	$0.45M	0.0%	-17.2%	0.055%
7/12/2024	SG Americas Securities LLC	111,592	$0.95M	0.0%	+861.5%	0.115%
5/20/2024	Virtu Financial LLC	20,201	$0.21M	0.0%	N/A	0.021%
5/17/2024	RA Capital Management L.P.	10,860,977	$111M	1.4%	+14.8%	11.210%
5/16/2024	California State Teachers Retirement System	32,658	$0.33M	0.0%	-3.4%	0.034%
5/16/2024	Levin Capital Strategies L.P.	55,250	$0.57M	0.1%	+5.7%	0.057%
5/16/2024	AWM Investment Company Inc.	100,000	$1.02M	0.1%	N/A	0.103%
5/16/2024	Jacobs Levy Equity Management Inc.	277,706	$2.84M	0.0%	+1,280.5%	0.287%
5/16/2024	Paloma Partners Management Co	10,093	$0.10M	0.0%	N/A	0.010%
5/15/2024	Public Employees Retirement System of Ohio	16,800	$0.17M	0.0%	N/A	0.017%
5/10/2024	Vanguard Group Inc.	2,886,455	$29.50M	0.0%	+37.0%	2.979%
5/8/2024	Russell Investments Group Ltd.	5,897	$60K	0.0%	N/A	0.006%
5/7/2024	ClariVest Asset Management LLC	272,956	$2.79M	0.3%	N/A	0.282%
5/7/2024	SG Americas Securities LLC	11,606	$0.12M	0.0%	N/A	0.012%
5/3/2024	GSA Capital Partners LLP	128,889	$1.32M	0.1%	+11.7%	0.133%
5/1/2024	Capstone Investment Advisors LLC	72,322	$0.74M	0.0%	N/A	0.075%
4/30/2024	J.W. Cole Advisors Inc.	13,900	$0.14M	0.0%	N/A	0.014%
4/29/2024	FAS Wealth Partners Inc.	60,470	$0.62M	0.1%	+31.5%	0.063%
4/29/2024	China Universal Asset Management Co. Ltd.	18,453	$0.19M	0.0%	+66.2%	0.019%
2/14/2024	Sectoral Asset Management Inc.	354,641	$1.94M	0.8%	-66.2%	0.369%
2/13/2024	Tower Research Capital LLC TRC	7,065	$39K	0.0%	-80.2%	0.007%
2/9/2024	Franklin Resources Inc.	4,098,497	$22.46M	0.0%	+5.9%	4.269%
2/6/2024	AJOVista LLC	7,822	$43K	0.1%	N/A	0.008%
2/6/2024	Levin Capital Strategies L.P.	52,250	$0.29M	0.0%	-61.0%	0.054%
2/6/2024	Swiss National Bank	66,000	$0.36M	0.0%	-19.8%	0.069%
1/25/2024	Nisa Investment Advisors LLC	5,600	$31K	0.0%	+22,300.0%	0.006%
1/24/2024	China Universal Asset Management Co. Ltd.	11,105	$61K	0.0%	+352.7%	0.012%
1/19/2024	Denali Advisors LLC	87,500	$0.48M	0.1%	N/A	0.091%
1/10/2024	Charles Schwab Trust Co	3,996,071	$21.90M	2.2%	-5.9%	4.163%
11/15/2023	Tejara Capital Ltd	103,739	$0.39M	0.2%	-22.3%	0.108%
11/15/2023	RA Capital Management L.P.	9,459,678	$35.76M	0.7%	+214.3%	9.854%
11/15/2023	Sectoral Asset Management Inc.	1,049,191	$3.97M	0.8%	-16.4%	1.093%
11/14/2023	Rubric Capital Management LP	639,203	$2.42M	0.1%	-77.2%	0.666%
11/13/2023	FMR LLC	1,307,340	$4.94M	0.0%	-72.0%	1.362%
11/13/2023	Tejara Capital Ltd	103,739	$0.39M	0.3%	-22.3%	0.108%
11/9/2023	Letko Brosseau & Associates Inc.	36,000	$0.14M	0.0%	N/A	0.038%
11/8/2023	Janney Montgomery Scott LLC	24,072	$91K	0.0%	-39.8%	0.025%
10/24/2023	Bank of New York Mellon Corp	83,924	$0.32M	0.0%	+9.1%	0.088%
10/23/2023	FAS Wealth Partners Inc.	45,970	$0.17M	0.0%	+34.2%	0.048%
10/20/2023	Charles Schwab Trust Co	4,246,071	$16.05M	1.8%	N/A	4.443%
10/12/2023	Brendel Financial Advisors LLC	19,125	$72K	0.1%	N/A	0.020%
10/11/2023	Vontobel Holding Ltd.	260,684	$0.99M	0.0%	-24.2%	0.273%
9/21/2023	Barclays PLC	20,460	$0.14M	0.0%	N/A	0.021%
8/14/2023	Caption Management LLC	73,400	$0.49M	0.0%	N/A	0.077%
8/11/2023	Sectoral Asset Management Inc.	1,255,640	$8.41M	1.4%	N/A	1.325%
8/11/2023	Rubric Capital Management LP	2,799,203	$18.76M	0.8%	-19.6%	2.954%
8/11/2023	Tejara Capital Ltd	133,521	$0.90M	0.4%	N/A	0.141%
8/10/2023	Nicholas Investment Partners LP	275,000	$1.84M	0.1%	N/A	0.290%
8/8/2023	FAS Wealth Partners Inc.	34,250	$0.23M	0.0%	N/A	0.036%
8/7/2023	Royce & Associates LP	463,700	$3.11M	0.0%	+52.6%	0.489%
8/4/2023	American International Group Inc.	11,672	$78K	0.0%	N/A	0.012%
8/1/2023	Arizona State Retirement System	10,606	$71K	0.0%	N/A	0.011%
7/31/2023	Levin Capital Strategies L.P.	169,074	$1.13M	0.1%	N/A	0.178%
7/28/2023	Shell Asset Management Co.	65,322	$0.44M	0.0%	N/A	0.069%
7/26/2023	Janney Montgomery Scott LLC	39,969	$0.27M	0.0%	N/A	0.042%
7/25/2023	DekaBank Deutsche Girozentrale	35,000	$0.23M	0.0%	N/A	0.037%
7/24/2023	Vontobel Holding Ltd.	344,029	$2.31M	0.0%	N/A	0.363%
7/19/2023	Teacher Retirement System of Texas	10,244	$69K	0.0%	N/A	0.011%
7/18/2023	Avantax Planning Partners Inc.	32,174	$0.22M	0.0%	N/A	0.034%
6/1/2023	Prelude Capital Management LLC	15,053	$98K	0.0%	N/A	0.016%
5/23/2023	Royce & Associates LP	303,900	$1.98M	0.0%	N/A	0.321%
5/19/2023	SR One Capital Management LP	4,012,903	$26.12M	8.9%	N/A	4.234%
5/16/2023	Baker BROS. Advisors LP	2,006,451	$13.06M	0.1%	N/A	2.121%

Data available starting January 2016

ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops treatments for severe allergic reactions. The company is developing neffy, a needle-free and low-dose intranasal epinephrine nasal spray for the emergency treatment of Type I allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.

Today's Range

Now: $15.72

$15.37

$16.44

50 Day Range

MA: $14.12

$11.36

$16.79

52 Week Range

Now: $15.72

$3.38

$17.08

Volume

925,936 shs

Average Volume

772,556 shs

Market Capitalization

$1.52 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.9

Who are the company insiders with the largest holdings of ARS Pharmaceuticals?: ARS Pharmaceuticals' top insider shareholders include:
Ra Capital Management, LP (Director)
Sarina Tanimoto (Insider)
Richard E Lowenthal (CEO)
Peter A Thompson (Director)
Laura Shawver (Director)
Alexander A Fitzpatrick (Insider)
Kathleen D Scott (CFO)
Brian Dorsey (COO)
Eric Karas (Insider)
Learn More about top insider investors at ARS Pharmaceuticals.
Who are the major institutional investors of ARS Pharmaceuticals?: ARS Pharmaceuticals' top institutional shareholders include:
Royce & Associates LP — 0.71%
Raymond James & Associates — 0.21%
Allspring Global Investments Holdings LLC — 0.18%
GSA Capital Partners LLP — 0.10%
SG Americas Securities LLC — 0.06%
Wealth Enhancement Advisory Services LLC — 0.06%
Learn More about top institutional investors of ARS Pharmaceuticals stock.
Which major investors are selling ARS Pharmaceuticals stock?: In the last quarter, SPRY stock was sold by these institutional investors:
SG Americas Securities LLC
In the last year, company insiders that have sold ARS Pharmaceuticals company stock include:
Ra Capital Management, LP (Director)
Sarina Tanimoto (Insider)
Richard E Lowenthal (CEO)
Peter A Thompson (Director)
Laura Shawver (Director)
Alexander A Fitzpatrick (Insider)
Learn More investors selling ARS Pharmaceuticals stock.
Which major investors are buying ARS Pharmaceuticals stock?: During the last quarter, SPRY stock was purchased by institutional investors including:
Raymond James & Associates
Allspring Global Investments Holdings LLC
Royce & Associates LP
GSA Capital Partners LLP
US Bancorp DE
TFG Advisers LLC
China Universal Asset Management Co. Ltd.
J.W. Cole Advisors Inc.
During the last year, these company insiders have bought ARS Pharmaceuticals stock:
Ra Capital Management, LP (Director)
Sarina Tanimoto (Insider)
Richard E Lowenthal (CEO)
Learn More investors buying ARS Pharmaceuticals stock.